At the time of writing, Orchestra BioMed Holdings Inc [OBIO] stock is trading at $5.78, up 1.85%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OBIO shares have gain 9.47% over the last week, with a monthly amount drifted -5.71%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Orchestra BioMed Holdings Inc [NASDAQ: OBIO] stock has seen the most recent analyst activity on August 22, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $14. Previously, B. Riley Securities started tracking the stock with Buy rating on July 25, 2024, and set its price target to $15. On January 19, 2024, Jefferies initiated with a Buy rating and assigned a price target of $14 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $15 on February 24, 2023. Chardan Capital Markets initiated its recommendation with a Buy and recommended $20 as its price target on February 07, 2023.
For the past year, the stock price of Orchestra BioMed Holdings Inc fluctuated between $4.22 and $11.69. Orchestra BioMed Holdings Inc [NASDAQ: OBIO] shares were valued at $5.78 at the most recent close of the market.
Analyzing the OBIO fundamentals
According to Orchestra BioMed Holdings Inc [NASDAQ:OBIO], the company’s sales were 2.65M for trailing twelve months, which represents an 135.56% jump. Gross Profit Margin for this corporation currently stands at 0.89% with Operating Profit Margin at -22.71%, Pretax Profit Margin comes in at -21.79%, and Net Profit Margin reading is -21.79%. To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -1.07 and Total Capital is -1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.55 points at the first support level, and at 5.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.01, and for the 2nd resistance point, it is at 6.24.
Ratios To Look Out For
It is important to note that Orchestra BioMed Holdings Inc [NASDAQ:OBIO] has a current ratio of 4.23. As well, the Quick Ratio is 4.21, while the Cash Ratio is 1.58. Considering the valuation of this stock, the price to sales ratio is 82.91, the price to book ratio is 4.75.
Transactions by insiders
Recent insider trading involved Hochman David P, that happened on Sep 25 ’24 when 7500.0 shares were purchased., Hochman David P completed a deal on Sep 24 ’24 to buy 2500.0 shares. Meanwhile, Sherman Darren sold 6804.0 shares on Sep 09 ’24.
